Lundbeck.
Danish pharmaceutical company
- Reports this week
- 0
- Active events
- 0
- Connections
- 92
What's happening
Earlier this month
One to three months ago
-
Lundbeck, a company, has established business roots in Illinois.Some support1 report
-
Charl van Zyl serves as CEO of Lundbeck, which is relocating its US headquarters to the Greater Boston hub.Some support3 reports
-
Lundbeck is presenting new data at the European Epilepsy Congress being held in Athens.Some support2 reports
-
European Commission granted orphan designation for Lundbeck's drug asedebart in the EU market.Some support3 reports
Gone quiet
No new reports in 90+ days-
The FDA granted Fast Track designation to Lu AH69593, a treatment associated with Lundbeck.Some support1 report
-
Lundbeck is leading a global Phase III trial, the DEEp OCEAN Trial, which is evaluating an investigational molecule.Some support6 reports
-
Lundbeck presents data at EAN Congress 2026.Some support2 reports
-
A study was presented at a meeting in Chicago involving Lundbeck and its R&D head, Johan Luthman.Some support1 report
-
UCB, Eisai, Lundbeck, and GW Pharmaceuticals are identified as key players in a market supported by supportive FDA policies.Some support1 report
No events began in the chosen period. Widen it, or reset.
What's reaching Lundbeck
Events traced to Lundbeck, step by step, newest firstAround Lundbeck this week
News at the entities that move Lundbeck most-
FDA StructuralAnavex Life Sciences submitted data for FDA discussions and received scientific advice from the EMA.Moves Lundbeck
-
European Commission StructuralBulgaria used a deficit procedure to avoid providing aid to Ukraine, while Germany linked EU budget approval to Ukraine funding.Moves Lundbeck
-
Food and Drug Administration StructuralSeaStar Medical submitted a premarket approval application to the FDA and discussed trial enrollment plans.Moves Lundbeck
-
Illinois StructuralMarkwayne Mullin blames violence on sanctuary politicians in Illinois.Moves Lundbeck
-
Greater Boston StructuralSouth End is confirmed to be a neighborhood within the city of Boston.Moves Lundbeck
-
Chicago Shared contextTampa's renter growth outpaced major US cities including New York, Chicago, and Philadelphia.Moves Lundbeck
Connections
The 15 strongest of 92, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Greater Boston Structural
Lundbeck is establishing its US headquarters and a new hub within the Greater Boston area.
-
FDA Structural
The FDA granted Orphan Drug Designation to a product of Lundbeck, establishing a formal regulatory dependency for market approval.
-
Lars Fruergaard Jørgensen Structural
Lars Fruergaard Jørgensen is proposed to chair the board of Lundbeck.
-
Charl van Zyl Structural
Charl van Zyl holds the position of CEO at Lundbeck.
-
Ingrid Scheffer Structural
Ingrid Scheffer serves as the lead investigator for a clinical program associated with Lundbeck.
-
Food and Drug Administration Structural
The FDA granted Fast Track designation to a product developed by Lundbeck.
-
Wenzel Structural
Wenzel served as the chair of the Lundbeck board.
-
European Commission Structural
The European Commission regulates Lundbeck by granting specific product designations, such as orphan designation.
Show all 15 connections
-
Johan Luthman Structural
Johan Luthman serves as the Executive Vice President and Head of Research & Development at Lundbeck.
-
European Academy of Neurology Mentioned together
Lundbeck utilized the EAN Congress platform to present new clinical data.
-
Cambridge Shared context
Lundbeck operates within the geographic and regulatory context of Cambridge, Massachusetts.
-
Illinois Structural
Lundbeck established its business roots and operational presence within Illinois.
-
Athens Shared context
Lundbeck is utilizing Athens as the location for presenting data at the European Epilepsy Congress.
-
Chicago Shared context
Lundbeck is conducting business activities, including studies and meetings, within the geographical boundaries of Chicago.
-
Denmark Shared context
Lundbeck is a biopharmaceutical company located in Denmark.